Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 265

1.

Decreased expression of c10orf10 and its prognostic significance in human breast cancer.

Deng J, Dong Y, Li C, Zuo W, Meng G, Xu C, Li J.

PLoS One. 2014 Jun 17;9(6):e99730. doi: 10.1371/journal.pone.0099730. eCollection 2014.

PMID:
24936657
[PubMed - in process]
Free PMC Article
2.

Cell-State Transitions Regulated by SLUG Are Critical for Tissue Regeneration and Tumor Initiation.

Phillips S, Prat A, Sedic M, Proia T, Wronski A, Mazumdar S, Skibinski A, Shirley SH, Perou CM, Gill G, Gupta PB, Kuperwasser C.

Stem Cell Reports. 2014 Apr 24;2(5):633-47. doi: 10.1016/j.stemcr.2014.03.008. eCollection 2014 May 6.

PMID:
24936451
[PubMed]
Free PMC Article
3.

Comparison of RNA-Seq by poly (A) capture, ribosomal RNA depletion, and DNA microarray for expression profiling.

Zhao W, He X, Hoadley KA, Parker JS, Hayes DN, Perou CM.

BMC Genomics. 2014 Jun 2;15:419. doi: 10.1186/1471-2164-15-419.

PMID:
24888378
[PubMed - in process]
Free PMC Article
4.

A shared transcriptional program in early breast neoplasias despite genetic and clinical distinctions.

Brunner AL, Li J, Guo X, Sweeney RT, Varma S, Zhu SX, Li R, Tibshirani R, West RB.

Genome Biol. 2014 May 23;15(5):R71. [Epub ahead of print]

PMID:
24887547
[PubMed - as supplied by publisher]
Free PMC Article
5.

Polarity gene alterations in pure invasive micropapillary carcinomas of the breast.

Gruel N, Benhamo V, Bhalshankar J, Popova T, Fréneaux P, Arnould L, Mariani O, Stern MH, Raynal V, Sastre-Garau X, Rouzier R, Delattre O, Vincent-Salomon A.

Breast Cancer Res. 2014 May 8;16(3):R46. [Epub ahead of print]

PMID:
24887297
[PubMed - as supplied by publisher]
Free PMC Article
6.

Molecular biology of brain metastasis.

Svokos KA, Salhia B, Toms SA.

Int J Mol Sci. 2014 May 28;15(6):9519-30. doi: 10.3390/ijms15069519.

PMID:
24879524
[PubMed - in process]
Free PMC Article
7.

MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer cells.

Wang Y, Lee YM, Baitsch L, Huang A, Xiang Y, Tong H, Lako A, Von T, Choi C, Lim E, Min J, Li L, Stegmeier F, Schlegel R, Eck MJ, Gray NS, Mitchison TJ, Zhao JJ.

Elife (Cambridge). 2014 May 20;3:e01763. doi: 10.7554/eLife.01763.

PMID:
24844244
[PubMed]
Free PMC Article
8.

Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer.

Mehner C, Hockla A, Miller E, Ran S, Radisky DC, Radisky ES.

Oncotarget. 2014 May 15;5(9):2736-49.

PMID:
24811362
[PubMed - in process]
Free PMC Article
9.

Multigene Assays for Classification, Prognosis, and Prediction in Breast Cancer: a Critical Review on the Background and Clinical Utility.

Sinn P, Aulmann S, Wirtz R, Schott S, Marmé F, Varga Z, Lebeau A, Kreipe H, Schneeweiss A.

Geburtshilfe Frauenheilkd. 2013 Sep;73(9):932-940.

PMID:
24771945
[PubMed]
Free PMC Article
10.

Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer.

Al-Ejeh F, Simpson PT, Sanus JM, Klein K, Kalimutho M, Shi W, Miranda M, Kutasovic J, Raghavendra A, Madore J, Reid L, Krause L, Chenevix-Trench G, Lakhani SR, Khanna KK.

Oncogenesis. 2014 Apr 21;3:e100. doi: 10.1038/oncsis.2014.14.

PMID:
24752235
[PubMed]
Free PMC Article
11.

Clinical validation of the EndoPredict test in node-positive, chemotherapy-treated ER+/HER2- breast cancer patients: results from the GEICAM 9906 trial.

Martin M, Brase JC, Calvo L, Krappmann K, Ruiz-Borrego M, Fisch K, Ruiz A, Weber KE, Munarriz B, Petry C, Rodriguez CA, Kronenwett R, Crespo C, Alba E, Carrasco E, Casas M, Caballero R, Rodriguez-Lescure A.

Breast Cancer Res. 2014 Apr 12;16(2):R38. doi: 10.1186/bcr3642.

PMID:
24725534
[PubMed - in process]
Free PMC Article
12.

Tissue specific DNA methylation in normal human breast epithelium and in breast cancer.

Avraham A, Cho SS, Uhlmann R, Polak ML, Sandbank J, Karni T, Pappo I, Halperin R, Vaknin Z, Sella A, Sukumar S, Evron E.

PLoS One. 2014 Mar 20;9(3):e91805. doi: 10.1371/journal.pone.0091805. eCollection 2014.

PMID:
24651077
[PubMed - in process]
Free PMC Article
13.

Systematic assessment of prognostic gene signatures for breast cancer shows distinct influence of time and ER status.

Zhao X, Rødland EA, Sørlie T, Vollan HK, Russnes HG, Kristensen VN, Lingjærde OC, Børresen-Dale AL.

BMC Cancer. 2014 Mar 19;14:211. doi: 10.1186/1471-2407-14-211.

PMID:
24645668
[PubMed - in process]
Free PMC Article
14.

A microRNA signature associated with early recurrence in breast cancer.

Pérez-Rivas LG, Jerez JM, Carmona R, de Luque V, Vicioso L, Claros MG, Viguera E, Pajares B, Sánchez A, Ribelles N, Alba E, Lozano J.

PLoS One. 2014 Mar 14;9(3):e91884. doi: 10.1371/journal.pone.0091884. eCollection 2014.

PMID:
24632820
[PubMed - in process]
Free PMC Article
15.

Baseline staging tests based on molecular subtype is necessary for newly diagnosed breast cancer.

Chen X, Sun L, Cong Y, Zhang T, Lin Q, Meng Q, Pang H, Zhao Y, Li Y, Cai L, Dong X.

J Exp Clin Cancer Res. 2014 Mar 17;33:28. doi: 10.1186/1756-9966-33-28.

PMID:
24628817
[PubMed - in process]
Free PMC Article
16.

Functional proteomic analysis reveals the involvement of KIAA1199 in breast cancer growth, motility and invasiveness.

Jami MS, Hou J, Liu M, Varney ML, Hassan H, Dong J, Geng L, Wang J, Yu F, Huang X, Peng H, Fu K, Li Y, Singh RK, Ding SJ.

BMC Cancer. 2014 Mar 15;14:194. doi: 10.1186/1471-2407-14-194.

PMID:
24628760
[PubMed - in process]
Free PMC Article
17.

Analytical validation of the PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Analysis System using formalin-fixed paraffin-embedded breast tumor specimens.

Nielsen T, Wallden B, Schaper C, Ferree S, Liu S, Gao D, Barry G, Dowidar N, Maysuria M, Storhoff J.

BMC Cancer. 2014 Mar 13;14:177. doi: 10.1186/1471-2407-14-177.

PMID:
24625003
[PubMed - in process]
Free PMC Article
18.

Nottingham Prognostic Index Plus (NPI+): a modern clinical decision making tool in breast cancer.

Rakha EA, Soria D, Green AR, Lemetre C, Powe DG, Nolan CC, Garibaldi JM, Ball G, Ellis IO.

Br J Cancer. 2014 Apr 2;110(7):1688-97. doi: 10.1038/bjc.2014.120. Epub 2014 Mar 11.

PMID:
24619074
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

A core invasiveness gene signature reflects epithelial-to-mesenchymal transition but not metastatic potential in breast cancer cell lines and tissue samples.

Marsan M, Van den Eynden G, Limame R, Neven P, Hauspy J, Van Dam PA, Vergote I, Dirix LY, Vermeulen PB, Van Laere SJ.

PLoS One. 2014 Feb 21;9(2):e89262. doi: 10.1371/journal.pone.0089262. eCollection 2014.

PMID:
24586640
[PubMed - in process]
Free PMC Article
20.

Clinicopathologic features of triple negative breast cancers: an experience from Pakistan.

Hashmi AA, Edhi MM, Naqvi H, Faridi N, Khurshid A, Khan M.

Diagn Pathol. 2014 Feb 28;9:43. doi: 10.1186/1746-1596-9-43.

PMID:
24581278
[PubMed - in process]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk